Publisher Correction: Advancing T cell-based cancer therapy with single-cell technologies
Nat Med
.
2024 May;30(5):1505.
doi: 10.1038/s41591-024-02841-x.
Authors
Samantha L Bucktrout
1
,
Nicholas E Banovich
2
,
Lisa H Butterfield
3
,
Cansu Cimen-Bozkus
3
4
,
Josephine R Giles
3
5
6
,
Zinaida Good
3
7
,
Daniel Goodman
3
8
,
Vanessa D Jonsson
9
10
11
,
Caleb Lareau
3
12
,
Alexander Marson
3
13
,
Deena M Maurer
3
,
Paul V Munson
3
,
Mike Stubbington
14
,
Sarah Taylor
14
,
Abbey Cutchin
14
Affiliations
1
Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.
[email protected]
.
2
Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ, USA.
3
Parker Institute of Cancer Immunotherapy, San Francisco, CA, USA.
4
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
5
Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania, Philadelphia, PA, USA.
6
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
7
Stanford Cancer Institute and Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA.
8
Microbiology and Immunology, School of Medicine, University of California San Francisco, San Francisco, CA, USA.
9
Department of Applied Mathematics, University of California, Santa Cruz, Santa Cruz, CA, USA.
10
Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA.
11
Genomics Institute, University of California, Santa Cruz, Santa Cruz, CA, USA.
12
Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
13
Gladstone-UCSF Institute for Genomic Immunology, San Francisco, CA, USA.
14
10x Genomics, Pleasanton, CA, USA.
PMID:
38317023
DOI:
10.1038/s41591-024-02841-x
No abstract available
Publication types
Published Erratum